Federation des caisses Desjardins du Quebec’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-30
Closed -$178 2965
2025
Q2
$178 Sell
30
-710
-96% -$3.75K ﹤0.01% 2637
2025
Q1
$3.6K Hold
740
﹤0.01% 2238
2024
Q4
$5.29K Hold
740
﹤0.01% 2070
2024
Q3
$5.89K Hold
740
﹤0.01% 2037
2024
Q2
$6.22K Hold
740
﹤0.01% 1915
2024
Q1
$8.07K Hold
740
﹤0.01% 1860
2023
Q4
$5.92K Hold
740
﹤0.01% 1871
2023
Q3
$7.2K Hold
740
﹤0.01% 1840
2023
Q2
$9.43K Hold
740
﹤0.01% 1772
2023
Q1
$6.79K Hold
740
﹤0.01% 1848
2022
Q4
$7.89K Hold
740
﹤0.01% 1933
2022
Q3
$2.96K Hold
740
﹤0.01% 2193
2022
Q2
$5.25K Buy
740
+216
+41% +$1.71K ﹤0.01% 2111
2022
Q1
$4.69K Hold
524
﹤0.01% 2212
2021
Q4
$5.86K Sell
524
-641
-55% -$8.01K ﹤0.01% 2163
2021
Q3
$16.4K Hold
1,165
﹤0.01% 1916
2021
Q2
$18.8K Buy
1,165
+185
+19% +$3.44K ﹤0.01% 1880
2021
Q1
$19.6K Buy
980
+750
+326% +$18K ﹤0.01% 1809
2020
Q4
$4.71K Hold
230
﹤0.01% 2092
2020
Q3
$4.02K Buy
+230
New +$3.65K ﹤0.01% 1899

Other funds holding PROF

Federation des caisses Desjardins du Quebec's PROF Position: Q3 2025 in Review

Federation des caisses Desjardins du Quebec sold out of Profound Medical (PROF) in Q3 2025, closing a stake of 30 shares — an estimated $178 sold.

Federation des caisses Desjardins du Quebec first reported a position in PROF in Q3 2020 and held it in 20 quarters. The position peaked at $19.6K in Q1 2021. 43 funds tracked by Wall St. Rank hold PROF as of Q3 2025.

  • Federation des caisses Desjardins du Quebec reported no remaining Profound Medical position as of Q3 2025 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 30 Profound Medical shares in Q3 2025, an estimated $178.
  • Federation des caisses Desjardins du Quebec first reported a position in Profound Medical in Q3 2020 and held it in 20 quarters.
  • Federation des caisses Desjardins du Quebec's Profound Medical position peaked at $19.6K in Q1 2021.
  • 43 funds tracked by Wall St. Rank held Profound Medical as of Q3 2025.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2025, filed 14 Nov 2025.